Annual EBIT:
$583.00M+$246.30M(+73.15%)Summary
- As of today, NBIX annual earnings before interest & taxes is $583.00 million, with the most recent change of +$246.30 million (+73.15%) on December 31, 2024.
- During the last 3 years, NBIX annual EBIT has risen by +$455.80 million (+358.33%).
- NBIX annual EBIT is now at all-time high.
Performance
NBIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$239.30M+$93.70M(+64.35%)Summary
- As of today, NBIX quarterly earnings before interest & taxes is $239.30 million, with the most recent change of +$93.70 million (+64.35%) on September 30, 2025.
- Over the past year, NBIX quarterly EBIT has increased by +$54.50 million (+29.49%).
- NBIX quarterly EBIT is now at all-time high.
Performance
NBIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$553.60M+$54.50M(+10.92%)Summary
- As of today, NBIX TTM earnings before interest & taxes is $553.60 million, with the most recent change of +$54.50 million (+10.92%) on September 30, 2025.
- Over the past year, NBIX TTM EBIT has dropped by -$34.70 million (-5.90%).
- NBIX TTM EBIT is now -5.90% below its all-time high of $588.30 million, reached on September 30, 2024.
Performance
NBIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NBIX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +73.2% | +29.5% | -5.9% |
| 3Y3 Years | +358.3% | +172.6% | +164.1% |
| 5Y5 Years | +642.7% | +222.5% | +62.5% |
NBIX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +358.3% | at high | +909.7% | -5.9% | +164.1% |
| 5Y | 5-Year | at high | +642.7% | at high | +7619.4% | -5.9% | +232.9% |
| All-Time | All-Time | at high | +374.7% | at high | +399.4% | -5.9% | +349.5% |
NBIX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $239.30M(+64.4%) | $553.60M(+10.9%) |
| Jun 2025 | - | $145.60M(+514.3%) | $499.10M(-0.5%) |
| Mar 2025 | - | $23.70M(-83.7%) | $501.40M(-14.0%) |
| Dec 2024 | $583.00M(+73.2%) | $145.00M(-21.5%) | $583.00M(-0.9%) |
| Sep 2024 | - | $184.80M(+24.9%) | $588.30M(+8.0%) |
| Jun 2024 | - | $147.90M(+40.5%) | $544.70M(+15.8%) |
| Mar 2024 | - | $105.30M(-29.9%) | $470.40M(+19.1%) |
| Dec 2023 | $336.70M(+52.4%) | $150.30M(+6.4%) | $394.80M(+12.9%) |
| Sep 2023 | - | $141.20M(+91.8%) | $349.60M(+18.0%) |
| Jun 2023 | - | $73.60M(+147.8%) | $296.20M(+6.8%) |
| Mar 2023 | - | $29.70M(-71.7%) | $277.30M(+10.6%) |
| Dec 2022 | $221.00M(+73.7%) | $105.10M(+19.7%) | $250.70M(+19.6%) |
| Sep 2022 | - | $87.80M(+60.5%) | $209.60M(+26.0%) |
| Jun 2022 | - | $54.70M(+1664.5%) | $166.30M(-7.3%) |
| Mar 2022 | - | $3.10M(-95.2%) | $179.40M(-13.7%) |
| Dec 2021 | $127.20M(-8.8%) | $64.00M(+43.8%) | $207.80M(-3.6%) |
| Sep 2021 | - | $44.50M(-34.4%) | $215.60M(-12.1%) |
| Jun 2021 | - | $67.80M(+115.2%) | $245.30M(-18.3%) |
| Mar 2021 | - | $31.50M(-56.1%) | $300.10M(-8.4%) |
| Dec 2020 | $139.50M(+77.7%) | $71.80M(-3.2%) | $327.50M(-3.9%) |
| Sep 2020 | - | $74.20M(-39.5%) | $340.70M(-4.5%) |
| Jun 2020 | - | $122.60M(+108.1%) | $356.60M(+30.4%) |
| Mar 2020 | - | $58.90M(-30.7%) | $273.46M(+20.7%) |
| Dec 2019 | $78.50M(+50.1%) | $85.00M(-5.7%) | $226.64M(+38.6%) |
| Sep 2019 | - | $90.10M(+128.3%) | $163.51M(+28.0%) |
| Jun 2019 | - | $39.46M(+226.6%) | $127.74M(+47.8%) |
| Mar 2019 | - | $12.08M(-44.7%) | $86.43M(+134.2%) |
| Dec 2018 | $52.30M(+142.5%) | $21.87M(-59.7%) | $36.90M(+37.4%) |
| Sep 2018 | - | $54.32M(+3033.2%) | $26.86M(+180.3%) |
| Jun 2018 | - | -$1.85M(+95.1%) | -$33.46M(+62.4%) |
| Mar 2018 | - | -$37.45M(-416.4%) | -$88.88M(+32.3%) |
| Dec 2017 | -$123.02M(+12.8%) | $11.83M(+297.4%) | -$131.36M(+30.7%) |
| Sep 2017 | - | -$6.00M(+89.5%) | -$189.45M(+14.6%) |
| Jun 2017 | - | -$57.27M(+28.4%) | -$221.89M(-7.5%) |
| Mar 2017 | - | -$79.93M(-72.8%) | -$206.45M(-40.1%) |
| Dec 2016 | -$141.09M(-58.7%) | -$46.25M(-20.3%) | -$147.37M(-11.8%) |
| Sep 2016 | - | -$38.44M(+8.1%) | -$131.87M(-2.0%) |
| Jun 2016 | - | -$41.83M(-100.5%) | -$129.28M(-14.6%) |
| Mar 2016 | - | -$20.86M(+32.2%) | -$112.77M(-19.7%) |
| Dec 2015 | -$88.93M(-38.1%) | -$30.75M(+14.2%) | -$94.20M(-12.2%) |
| Sep 2015 | - | -$35.84M(-41.6%) | -$83.92M(-29.2%) |
| Jun 2015 | - | -$25.32M(-1006.7%) | -$64.94M(-20.3%) |
| Mar 2015 | - | -$2.29M(+88.8%) | -$53.97M(+16.2%) |
| Dec 2014 | -$64.41M(-29.7%) | -$20.47M(-21.4%) | -$64.41M(-16.1%) |
| Sep 2014 | - | -$16.86M(-17.4%) | -$55.47M(-9.6%) |
| Jun 2014 | - | -$14.36M(-12.9%) | -$50.62M(-2.4%) |
| Mar 2014 | - | -$12.72M(-10.4%) | -$49.43M(+0.5%) |
| Dec 2013 | -$49.68M(-3530.8%) | -$11.53M(+4.0%) | -$49.68M(-68.0%) |
| Sep 2013 | - | -$12.01M(+8.8%) | -$29.57M(-37.4%) |
| Jun 2013 | - | -$13.17M(-1.5%) | -$21.52M(-121.1%) |
| Mar 2013 | - | -$12.97M(-251.2%) | -$9.73M(-772.3%) |
| Dec 2012 | $1.45M(-95.7%) | $8.58M(+316.6%) | $1.45M(+121.6%) |
| Sep 2012 | - | -$3.96M(-187.1%) | -$6.69M(-124.2%) |
| Jun 2012 | - | -$1.38M(+23.0%) | $27.62M(-8.2%) |
| Mar 2012 | - | -$1.79M(-507.3%) | $30.10M(-11.3%) |
| Dec 2011 | $33.92M(+347.2%) | $440.00K(-98.6%) | $33.93M(-5.1%) |
| Sep 2011 | - | $30.35M(+2669.4%) | $35.76M(+347.5%) |
| Jun 2011 | - | $1.10M(-46.2%) | $7.99M(+602.1%) |
| Mar 2011 | - | $2.04M(-10.1%) | $1.14M(+110.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$13.72M(+73.2%) | $2.27M(-12.3%) | -$10.92M(+50.5%) |
| Sep 2010 | - | $2.59M(+144.9%) | -$22.05M(+35.7%) |
| Jun 2010 | - | -$5.76M(+42.6%) | -$34.27M(+21.1%) |
| Mar 2010 | - | -$10.02M(-13.2%) | -$43.41M(+9.0%) |
| Dec 2009 | -$51.11M(+37.4%) | -$8.85M(+8.1%) | -$47.69M(+11.4%) |
| Sep 2009 | - | -$9.63M(+35.4%) | -$53.80M(+10.1%) |
| Jun 2009 | - | -$14.90M(-4.2%) | -$59.88M(+8.0%) |
| Mar 2009 | - | -$14.30M(+4.5%) | -$65.09M(+9.0%) |
| Dec 2008 | -$81.59M(+61.6%) | -$14.97M(+4.7%) | -$71.56M(+15.1%) |
| Sep 2008 | - | -$15.70M(+21.9%) | -$84.28M(+13.5%) |
| Jun 2008 | - | -$20.12M(+3.1%) | -$97.40M(+7.1%) |
| Mar 2008 | - | -$20.76M(+25.0%) | -$104.83M(+5.8%) |
| Dec 2007 | -$212.24M(-87.3%) | -$27.69M(+3.9%) | -$111.34M(-11.4%) |
| Sep 2007 | - | -$28.83M(-4.6%) | -$99.91M(+1.8%) |
| Jun 2007 | - | -$27.55M(-1.0%) | -$101.78M(+1.7%) |
| Mar 2007 | - | -$27.27M(-67.7%) | -$103.50M(+0.3%) |
| Dec 2006 | -$113.32M(-352.0%) | -$16.26M(+47.0%) | -$103.82M(+7.4%) |
| Sep 2006 | - | -$30.70M(-4.9%) | -$112.15M(-99.1%) |
| Jun 2006 | - | -$29.26M(-6.1%) | -$56.33M(-69.1%) |
| Mar 2006 | - | -$27.59M(-12.2%) | -$33.32M(-32.9%) |
| Dec 2005 | -$25.07M(+52.1%) | -$24.59M(-197.9%) | -$25.07M(-15.7%) |
| Sep 2005 | - | $25.12M(+501.8%) | -$21.66M(+56.5%) |
| Jun 2005 | - | -$6.25M(+67.7%) | -$49.81M(+12.5%) |
| Mar 2005 | - | -$19.35M(+8.7%) | -$56.95M(-8.8%) |
| Dec 2004 | -$52.33M(+11.0%) | -$21.18M(-598.9%) | -$52.33M(-7.9%) |
| Sep 2004 | - | -$3.03M(+77.4%) | -$48.52M(+17.9%) |
| Jun 2004 | - | -$13.39M(+9.1%) | -$59.06M(-1.5%) |
| Mar 2004 | - | -$14.73M(+15.2%) | -$58.16M(+1.1%) |
| Dec 2003 | -$58.79M(+43.3%) | -$17.37M(-28.0%) | -$58.79M(+28.9%) |
| Sep 2003 | - | -$13.57M(-8.7%) | -$82.69M(+9.7%) |
| Jun 2003 | - | -$12.49M(+18.6%) | -$91.62M(+9.4%) |
| Mar 2003 | - | -$15.35M(+62.8%) | -$101.15M(+2.4%) |
| Dec 2002 | -$103.61M(-136.1%) | -$41.27M(-83.4%) | -$103.61M(-33.3%) |
| Sep 2002 | - | -$22.50M(-2.2%) | -$77.75M(-43.8%) |
| Jun 2002 | - | -$22.02M(-23.6%) | -$54.05M(-13.5%) |
| Mar 2002 | - | -$17.82M(-15.7%) | -$47.62M(-8.5%) |
| Dec 2001 | -$43.88M(-23.3%) | -$15.40M(-1391.2%) | -$43.88M(-10.3%) |
| Sep 2001 | - | $1.19M(+107.7%) | -$39.79M(+21.5%) |
| Jun 2001 | - | -$15.59M(-10.7%) | -$50.67M(-19.3%) |
| Mar 2001 | - | -$14.08M(-24.5%) | -$42.45M(-19.2%) |
| Dec 2000 | -$35.60M(-78.9%) | -$11.31M(-16.8%) | -$35.60M(-21.7%) |
| Sep 2000 | - | -$9.69M(-31.2%) | -$29.26M(-19.2%) |
| Jun 2000 | - | -$7.38M(-2.1%) | -$24.55M(-8.9%) |
| Mar 2000 | - | -$7.23M(-45.5%) | -$22.55M(-13.6%) |
| Dec 1999 | -$19.90M(-60.5%) | -$4.97M(+0.3%) | -$19.85M(-28.5%) |
| Sep 1999 | - | -$4.98M(+7.4%) | -$15.45M(+3.0%) |
| Jun 1999 | - | -$5.38M(-18.9%) | -$15.92M(-10.1%) |
| Mar 1999 | - | -$4.53M(-708.2%) | -$14.45M(-16.9%) |
| Dec 1998 | -$12.40M(-2580.0%) | -$560.00K(+89.7%) | -$12.36M(+5.6%) |
| Sep 1998 | - | -$5.45M(-39.3%) | -$13.10M(-62.8%) |
| Jun 1998 | - | -$3.91M(-60.9%) | -$8.05M(-59.9%) |
| Mar 1998 | - | -$2.43M(-87.2%) | -$5.03M(-938.8%) |
| Dec 1997 | $500.00K(-82.8%) | -$1.30M(-225.0%) | $600.00K(-88.5%) |
| Sep 1997 | - | -$400.00K(+55.6%) | $5.20M(+26.8%) |
| Jun 1997 | - | -$900.00K(-128.1%) | $4.10M(-34.9%) |
| Mar 1997 | - | $3.20M(-3.0%) | $6.30M(+117.2%) |
| Dec 1996 | $2.90M | $3.30M(+320.0%) | $2.90M(+825.0%) |
| Sep 1996 | - | -$1.50M(-215.4%) | -$400.00K(-136.4%) |
| Jun 1996 | - | $1.30M(+750.0%) | $1.10M(+650.0%) |
| Mar 1996 | - | -$200.00K | -$200.00K |
FAQ
- What is Neurocrine Biosciences, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual EBIT year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly EBIT year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM EBIT year-on-year change?
What is Neurocrine Biosciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of NBIX is $583.00M
What is the all-time high annual EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual earnings before interest & taxes is $583.00M
What is Neurocrine Biosciences, Inc. annual EBIT year-on-year change?
Over the past year, NBIX annual earnings before interest & taxes has changed by +$246.30M (+73.15%)
What is Neurocrine Biosciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of NBIX is $239.30M
What is the all-time high quarterly EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly earnings before interest & taxes is $239.30M
What is Neurocrine Biosciences, Inc. quarterly EBIT year-on-year change?
Over the past year, NBIX quarterly earnings before interest & taxes has changed by +$54.50M (+29.49%)
What is Neurocrine Biosciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of NBIX is $553.60M
What is the all-time high TTM EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM earnings before interest & taxes is $588.30M
What is Neurocrine Biosciences, Inc. TTM EBIT year-on-year change?
Over the past year, NBIX TTM earnings before interest & taxes has changed by -$34.70M (-5.90%)